Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
739
Zitationen
17
Autoren
2015
Jahr
Abstract
The results of this study did not show the noninferiority of the strategy of no further treatment after chemotherapy with regard to progression-free survival. Nevertheless, patients in this study with early-stage Hodgkin's lymphoma and negative PET findings after three cycles of ABVD had a very good prognosis either with or without consolidation radiotherapy. (Funded by Leukaemia and Lymphoma Research and others; RAPID ClinicalTrials.gov number, NCT00943423.).
Ähnliche Arbeiten
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
2012 · 18.365 Zit.
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
1997 · 11.421 Zit.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2000 · 9.919 Zit.
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 · 8.398 Zit.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · 7.754 Zit.
Autoren
Institutionen
- London Cancer(GB)
- University College London(GB)
- Manchester Academic Health Science Centre(GB)
- Cancer Research UK(GB)
- Weston Park Cancer Centre(GB)
- University of Sheffield(GB)
- Universidad de Londres(MX)
- University of London(GB)
- NIHR CRUK Experimental Cancer Medicine Centre(GB)
- Norfolk and Norwich University Hospital(GB)
- Aberdeen Royal Infirmary(GB)
- Nottingham City Hospital(GB)
- Queen's Hospital(GB)
- Royal Cornwall Hospital Trust(GB)
- St Bartholomew's Hospital(GB)
- Mount Vernon Hospital(GB)
- Kings Health Partners(GB)
- St Thomas' Hospital(GB)
- King's College London(GB)
- St. Thomas Hospital(CA)